US Broker Ratings

Glaukos Corporation (GKOS): Investor Outlook and Key Metrics Highlighting a Promising 11.98% Upside

Glaukos Corporation (NYSE: GKOS) stands at the forefront of innovative solutions in the ophthalmic medical device sector, making it a fascinating prospect for investors within the healthcare industry. With a..

Humana Inc. (HUM) Investor Outlook: Exploring a 7.45% Potential Upside in Healthcare Plans

Humana Inc. (NYSE: HUM), a prominent player in the healthcare plans sector, is drawing considerable interest from investors with its solid performance and strategic positioning in a competitive industry. Headquartered..

Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook on a Booming Biotech with 362% Revenue Growth

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has captured the attention of investors in the healthcare sector with its remarkable revenue growth and its strategic focus on developing novel therapeutics for metabolic..

Roivant Sciences (ROIV) Stock Analysis: A Promising Biotech with a 16% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with a market capitalization of $15.37 billion. Based in London, United Kingdom, Roivant focuses..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with a 15% Upside Potential

argenx SE (ARGX), a prominent player in the biotechnology sector, commands significant attention with its cutting-edge therapies for autoimmune diseases. Based in Amsterdam, Netherlands, this commercial-stage biopharmaceutical company is making..

Stevanato Group S.p.A. (STVN) Investor Outlook: 37.56% Potential Upside Captures Attention

Italy-based Stevanato Group S.p.A. (NYSE: STVN) is making waves in the healthcare sector, particularly in the medical instruments and supplies industry. With a market capitalization of $5.68 billion, Stevanato is..

BioNTech SE (BNTX) Stock Analysis: Navigating a 46.33% Potential Upside in the Biotechnology Sector

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has captured the attention of investors with a significant potential upside of 46.33%, according to the latest analyst ratings...

Solventum Corporation (SOLV) Stock Analysis: Evaluating the 1.67% Potential Upside in Healthcare

Solventum Corporation (SOLV), a prominent player in the healthcare sector, has drawn significant attention from investors due to its comprehensive portfolio of medical instruments and supplies. Operating from its Maplewood,..

Hologic, Inc. (HOLX) Investor Outlook: Stability in Women’s Health Sector with Modest Upside

Hologic, Inc. (NASDAQ: HOLX), a formidable player in the healthcare sector, commands attention with its robust portfolio of diagnostics, medical imaging systems, and surgical products tailored for women’s health. With..

CVS Health Corporation (CVS) Stock Analysis: Unpacking an 18% Upside Potential for Investors

CVS Health Corporation (NYSE: CVS) is a major player in the healthcare sector, commanding a market capitalization of $100.82 billion. As a multifaceted healthcare company, CVS operates through three primary..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Biotech Powerhouse with 21 Buy Ratings and a Promising Pipeline

Revolution Medicines, Inc. (NASDAQ: RVMD) is capturing the attention of investors with its innovative approach to tackling RAS-addicted cancers, a notoriously challenging area in oncology. With a market capitalization of..

Doximity, Inc. (DOCS) Stock Analysis: Evaluating a 55.64% Potential Upside in the Health Information Sector

As the healthcare industry continues to evolve, digital platforms like Doximity, Inc. (NYSE: DOCS) are playing an increasingly pivotal role. With a current market capitalization of $8.26 billion, Doximity stands..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating Growth in the Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS), a leading player in the healthcare sector, has captured investor attention with its innovative approach to cancer diagnostics and screening. With a market capitalization of..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Potential Upside Amidst Revenue Challenges

Avantor, Inc. (AVTR), a key player in the healthcare sector, operates within the medical instruments and supplies industry, providing invaluable mission-critical products and services across a global landscape. With a..

Incyte Corporation (INCY): Analyst Ratings Highlight Growth Potential Amid Market Volatility

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, is making headlines with its strong financial performance and promising pipeline of therapeutic products. With a market capitalization of..

Waters Corporation (WAT) Stock Analysis: A Healthcare Giant with a 2.43% Potential Upside

Waters Corporation (NYSE: WAT), a stalwart in the healthcare sector, continues to be a significant player in the diagnostics and research industry. With a market capitalization of $22.94 billion, the..

Teva Pharmaceutical (TEVA) Stock Analysis: Exploring Growth Potential Amidst Robust Analyst Ratings

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a prominent player in the global pharmaceutical landscape, primarily recognized for its expansive portfolio of generic and specialty medicines. With a market capitalization..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: A Deep Dive into its 23.94% Potential Upside

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a beacon of innovation in the healthcare sector, specifically within the biotechnology industry. With a robust market capitalization of $52.52 billion, this Massachusetts-based..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating the 5.61% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) continues to captivate the attention of investors as it stands at the forefront of the biotechnology industry with a robust portfolio and promising growth potential...

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant Poised for a 11.50% Upside

For investors seeking exposure in the healthcare sector, Cencora, Inc. (NYSE: COR) presents a compelling opportunity. Formerly known as AmerisourceBergen Corporation, the company rebranded as Cencora in August 2023, marking..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds